secwatch.observer — SEC 8-K summary
======================================

Issuer:     Werewolf Therapeutics, Inc. (HOWL)
CIK:        0001785530
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001193125-25-140727
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Werewolf Therapeutics adopts amended bylaws, elects directors at annual meeting
-------------------------------------------------------------------------------

- Board adopted Third Amended and Restated Bylaws effective June 12, 2025, updating stockholder nomination and proposal procedures.
- Stockholders elected Briggs Morrison, Michael Sherman, and Anil Singhal as Class I directors for three-year terms ending 2028.
- Director vote results: Morrison 19.16M for / 6.33M withheld; Sherman 20.66M for / 4.82M withheld; Singhal 24.58M for / 0.91M withheld.
- Ratified Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2025 (33.50M for, 31K against, 84K abstain).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785530/000119312525140727/0001193125-25-140727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785530/000119312525140727/d49208d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-140727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer